Molecular cloning and characterization of decay-accelerating factor deficiency in cromer blood group inab phenotype

Blood

Volumn 91, Issue 2, 1998, Pages 680-684

  Wang, Li ^b   Uchikaw, Makoto ^a   Tsuneyama, Hatsue ^b   Tokunaga, Katsushi ^b   Tadokoro, Kenji ^b   Juji, Takeo ^b  

^a JAPANESE RED CROSS MEDICAL CENTER   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DECAY ACCELERATING FACTOR; GLYCOSYLPHOSPHATIDYLINOSITOL;

ADULT; ARTICLE; BLOOD GROUP; CARBOXY TERMINAL SEQUENCE; CASE REPORT; CELL SURFACE; CONSENSUS SEQUENCE; ERYTHROCYTE; FEMALE; FRAMESHIFT MUTATION; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MOLECULAR CLONING; NUCLEIC ACID BASE SUBSTITUTION; PHENOTYPE; PRIORITY JOURNAL; RNA TRANSLATION; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; STOP CODON;

EID: 0031973130     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.2.680.680_680_684     Document Type: Article

References (28)

1. Lublin DM, Atkinson JP: Decay-accelerating factor: Biochemistry, molecular biology and function. Ann Rev Immunol 7:35, 1989
2. Lublin DM, Lemons RS, LeBeau MM, Holers VM, Tykocinski ML, Medof ME, Atkinson JP: The gene encoding decay-accelerating factor (DAF) is located in the complement-regulatory locus on the long arm of chromosome 1. J Exp Med 165:1731, 1987
3. Rey-Campos J, Rubinstein P, Rodriguez de Cordoba S: Decay-acceleratinng factor. Genetic polymorphism and linkage to the RCA (regulator of complement activation) gene cluster in humans. J Exp Med 166:246, 1987
4. Nicholson-Weller A, Burge J, Fearon DT, Weller PF, Austen KF: Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3-convertases of the complement system. J Immunol 129:184, 1982
5. Pangburn MK, Schreiber RD, Trombold JS, Muller-Eberhard HJ: Paroxysmal nocturnal haemoglobinurea: Deficiency in factor H-like functions of the abnormal erythrocytes. J Exp Med 157:1971, 1983
6. Medof ME, Kinoshita T, Silber R, Nussenzweig V: Amelioration of lytic abnormalities of paroxysmal nocturnal hemoglobinuria with decay-accelerating factor. Proc Natl Acad Sci USA 82:2980, 1985
7. Rosse WF: The control of complement activation by the blood cells in paroxysmal nocturnal hemoglobinuria. Blood 67:268, 1986
8. Kinoshita T: Host cell protection from complement by glycosylphosphatidylinositol-anchored complement inhibitors and their deficiencies in paroxysmal nocturnal haemoglobinuria, in Melchers F, Albert ED, Nichlin L (eds): Progress in Immunology (vol 7). New York, NY, Springer-Verlag, 1989. p 178
9. Coyne K, Hall S, Thompson E, Arce MA, Kinoshita T, Fujita T, Anstee DA, Rosse WF, Lublin DM: Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor. J Immunol 149:2906, 1992
10. Lublin DM, Krsek-Staples J, Pangburn MK, Atkinson JP: Biosynthesis and glycosylation of the human complement regulatory protein decay-accelerating factor. J Immunol 137:1629, 1986
11. Nicholson-Weller A, Wang CE: Structure and function of decay accelerating factor CDSS. J Lab Clin Med 123:485, 1994
12. Telen MJ, Hall SE, Green AM, Moulds JJ, Rosse WF: Identification of human erythrocyte blood group antigens on decay accelerating factor (DAF) and an-erythrocyte pheuotype negative for DAF. J Exp Med 167:93, 1988
13. Parsons SF, Spring FA, Meny AH, Uchikawa M, Mallinoson G, Anstee DJ, Rawiison V, Daha M: Evidence that Cromer-related blood group antigens are carried on decay accelerating factor (DAF) suggests that the Inab. phenotype is a novel form of DAF deficiency. 20th Congr Int Soc Blood Transfus 116, 1988 (abstr)
14. Daniels GL: Cromer-related antigens-blood group determinants on decay-accelerating factor. Vox Sang 56:205, 1988
15. Daniels GL, Tohyama H, Uchikawa M: A possible null phenotype in the Cromer blood group complex. Transfusion 22:362, 1982
16. Walthers L, Salem M, Tessel J, Laird-Fryer B, Moulds JJ: The Inab phenotype: Another example found. Transfusion 23:423, 1983 (abstr)
17. Lin RC, Herman J, Henry L, Daniels GL: A family showing inheritance of the Inab phenotype. Transfusion 28:427, 1988
18. Tate CG, Uchikawa M, Tanner MJA, Judson PA, Parsons SF, Mallinson G, Anstee DJ: Studies on the defect which causes absence of decay accelerating factor (DAF) from the peripheral blood cells of an individual with the Inab phenotype. Biochem J 261:489, 1989
19. Lublin DM, Mallinson G, Poole J, Reid ME, Thompson ES, Ferdman BR, Telen MJ, Anstee DJ, Tanner MJA: Molecular basis of reduced or absent expression of decay-accelerating factor in Cromer blood group phenotypes. Blood 84:1276, 1994
20. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
21. Medof ME, Lublin DM, Holers MH, Ayers DJ, Getty RR, Leykam JF, Atkinson JP, Tykocinski ML: Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement. Proc Natl Acad Sci USA 84:2007, 1987
22. Ewulonu UK, Ravi L, Medof ME: Characterization of the decay-accelerating factor gene promoter region. Proc Natl Acad Sci USA 88:4675, 1991
23. Nowicki B, Moulds J, Hull R, Hull S: A hemagglutinin of uropathogenic Escherichia coli recognizes the Dr blood group antigen. Infect Immun 56:1057, 1988
24. Yamashina M, Ueda E, Kinoshita T, Takami T, Ojima A, Ono H, Tanaka H, Kondo N, Orii T, Okada N, Okada H, Inoue K, Kitani T: Inherited complete deficiency of 20-kilodalton homologous restriction factor (CD59) as a cause of paroxysmal nocturnal hemoglobinuria. N Engl J Med 323: 1184, 1990
25. Bannai M, Tokunaga K, Lin L, Kuwata S, Mazda T, Amaki I, Fujisawa K, Juji T: Discrimination of human HLA-DRB1 alleles by PCR-SSCP method. Eur J Immunogenet 21:1, 1994
26. Shapiro MB, Senapathy P: RNA splice junctions of different classes of eukaryotes: Sequence statistics and functional implications in gene expression. Nucleic Acids Res 15:7155, 1987
27. Krawczak M, Reiss J, Cooper DN: The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: Causes and consequences. Hum Genet 90:41, 1992
28. Reid ME, Mallinson G, Sim RB, Poole J, Pausch V, Merry AH, Liew YW, Tanner MJA: Biochemical studies on the red blood cells from a patient with the Inab phenotype (decay-accelerating factor deficiency). Blood 78:3291, 1991